Skip to menu Skip to content Skip to footer
Dr Kelvin Tuong
Dr

Kelvin Tuong

Email: 
Phone: 
+61 7 3069 7506

Overview

Background

Dr. Kelvin Tuong is a Senior Research Fellow/Group Leader at the Ian Frazer Centre for Children’s Immunotherapy Research (IFCCIR), Child Health Research Centre. He is interested in single-cell analysis of immune cells and harnessing adaptive immune receptors for understanding immune cell development and function in health and in cancer.

Dr. Tuong was born and raised in Singapore and moved to Brisbane, Australia, after completing national service in Singapore and obtaining a Diploma in Biomedical Laboratory Technology (Ngee Ann Polytechnic).

Dr. Tuong was originally trained as a molecular cell biologist and gradually transitioned into bioinformatics during his post-doctoral training. He has been very prolific for an early career researcher, having published >70 articles since 2013, with nearly a third of them as first/co-first or last author and has a stellar track record of pushing out highly collaborative work in prestigious journals including Nature, Cell, Science, Nature Medicine, Nature Biotechnology J Exp Med etc. He has the rare combination of having excellent laboratory and bioinformatics skill sets which provide him a strong command of both fundamental immunology and computational approaches.

Dr. Tuong completed his undergraduate Bachelor's degree in Biomedical science with Class I Honours, followed by his PhD in macrophage cell biology and endocrinology at UQ (Prof. Jenny Stow lab and Emiritus Prof. George Muscat lab, IMB, UQ). He then went on to a post-doc position with Emiritus Prof. Ian Frazer (co-inventor of the Gardasil cervical cancer vaccine, UQ Frazer Institute, Translational Research Institute) where he worked on HPV immunology, cervical cancer and skin cancer. In his time in the Frazer lab, he developed an interest in bioinformatics analyses as a means to tackle and understanding immunology problems in health and disease. He then moved to the UK and joined Prof. Menna Clatworthy's lab at the University of Cambridge and Dr. Sarah Teichmann's lab at the Wellcome Trust Sanger Institute. He has focused his interests on single-cell analyses of tissue immune cells, including T and B cells and their specific receptors (TCR/BCR). He has developed bespoke bioinformatics software, including one tailored for single-cell B Cell Receptor sequencing analysis, Dandelion, which he used in one of the largest combined single-cell transcriptomic, surface proteomic and TCR/BCR sequencing dataset in the world, published in Nature Medicine, and more recently in Nature Biotechnology where we introduced a TCR-based pseudotime trajectory analysis method.

Dr. Tuong is now leading the Computational Immunology group at the IFCCIR and his lab is focused on investigating how pediatric immunity is perturbed during cancer at the cellular level and how this information can be used for creating novel warning systems for children with cancer. For potential students/post-docs/trainees interested in joining the team, please contact Dr. Tuong at z.tuong@uq.edu.au.

Availability

Dr Kelvin Tuong is:
Available for supervision
Media expert

Qualifications

  • Doctor of Philosophy, The University of Queensland

Research interests

  • Deep learning of immune repertoires

    T cells and B cells play a critical role in recognizing and eliminating cancer cells through their highly specific adaptive immune receptors. Our vision is to harness the power of these receptors to enable early cancer detection and real-time disease monitoring, particularly in children. These receptors act as natural "time-keepers" of the immune system’s engagement with tumors, capturing a molecular history of the immune response as cancer progresses. Our research focuses on understanding the properties that make these immune cells effective in the context of childhood cancers. Using high-resolution single-cell gene expression profiling, we aim to uncover how T and B cells behave in pediatric patients and how their receptors evolve during disease and treatment. To achieve this, we are developing new computational tools and algorithms designed to analyze immune receptor sequences and their expression patterns. Using deep learning, we aim to identify receptor signatures that are specific to cancer, and use these patterns to predict therapeutic responses and monitor disease progression in children with blood cancers. This approach offers a path toward highly sensitive tool for early detection and long-term monitoring of pediatric immunity and cancer.

  • Single-cell prediction of cancer cells

    We’re interested in using deep learning to make sense of single-cell RNA sequencing (scRNA-seq) data, especially to uncover copy number variations (CNVs) that are often hidden in the noise of single-cell measurements. CNVs are a key feature in many cancers, but detecting them reliably at the single-cell level is still a challenge. Rather than relying on traditional approaches that often struggle with the sparse and noisy nature of scRNA-seq, we’re exploring how deep learning models can be trained to recognize subtle patterns in gene expression that point to underlying genomic alterations. Our goal is to build tools that can separate cancer cells from normal cells based on these inferred CNVs, helping us better understand tumor composition, heterogeneity, and evolution. This work has implications not just for identifying malignant cells, but also for tracking how tumors change over time or respond to treatment. We’re also interested in combining this with other data types—like epigenomic or spatial information—to build a more complete picture of what’s happening inside tumors at the single-cell level. We approach this work from both a computational and biological perspective, and we’re motivated by the potential for these methods to contribute to more personalized and effective cancer diagnostics.

  • Paediatric Immune Cell Atlas

    We’re building the largest immune cell atlas of Australian children to date, profiling blood samples from over 1,000 healthy and disease-affected children using single-cell RNA sequencing (scRNA-seq). Our goal is to create a high-resolution map of the developing immune system in early life—a period when immune function is still maturing and highly dynamic. Children’s immune systems differ significantly from those of adults, yet they remain understudied in immunology. By analyzing immune cell populations at single-cell resolution, we’re uncovering how these cells change with age, how they respond to infections or immune-related diseases, and how early-life immunity is shaped by both genetic and environmental factors. To fully capture the complexity of the pediatric immune system, we’re incorporating machine learning and deep learning approaches to uncover subtle patterns and rare cell states across this large and diverse dataset. We’re also applying integrative methods to link scRNA-seq data with immune repertoire sequencing, enabling us to explore how T and B cell clonality and diversity contribute to immune development and disease. This work has important implications for understanding pediatric diseases, identifying early biomarkers of immune dysregulation, and designing age-specific diagnostics and therapies. In addition to its clinical relevance, the atlas will serve as a foundational reference for researchers working in pediatric immunology and systems biology.

Works

Search Professor Kelvin Tuong’s works on UQ eSpace

96 works between 2013 and 2025

1 - 20 of 96 works

2025

Journal Article

In vivo labelling resolves distinct temporal, spatial, and functional properties of tumour macrophages, and identifies subset-specific effects of PD-L1 blockade

Lee, Colin Y. C., Dean, Isaac, Richoz, Nathan, Li, Zhi, Kennedy, Bethany C., Vettore, Lisa A., Samarakoon, Youhani, Gilroy, Kathryn L., Hasegawa, Tetsuo, Carlesso, Gianluca, Hammond, Scott A., Dovedi, Simon J., Sansom, Owen J., Tuong, Zewen K., Halim, Timotheus YF., Withers, David R. and Clatworthy, Menna R. (2025). In vivo labelling resolves distinct temporal, spatial, and functional properties of tumour macrophages, and identifies subset-specific effects of PD-L1 blockade. Cancer Immunology Research, 13 (9), 1453-1470. doi: 10.1158/2326-6066.cir-24-1233

In vivo labelling resolves distinct temporal, spatial, and functional properties of tumour macrophages, and identifies subset-specific effects of PD-L1 blockade

2025

Journal Article

scRepertoire 2: Enhanced and efficient toolkit for single-cell immune profiling

Yang, Qile, Safina, Ksenia R., Nguyen, Kieu Diem Quynh, Tuong, Zewen Kelvin and Borcherding, Nicholas (2025). scRepertoire 2: Enhanced and efficient toolkit for single-cell immune profiling. PLOS Computational Biology, 21 (6) e1012760, e1012760-6. doi: 10.1371/journal.pcbi.1012760

scRepertoire 2: Enhanced and efficient toolkit for single-cell immune profiling

2025

Journal Article

Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome

Case, A. G., O’Brien, J. W., Lu, Y., Charlier, F. T. W., Zhao, X., Weng, Y., Masters, L., Tuong, Z. K., Sriranjan, R., Cheriyan, J., Kemper, C., Clatworthy, M. R., Mallat, Z. and Zhao, T. X. (2025). Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome. Nature Cardiovascular Research, 4 (6) 40, 727-739. doi: 10.1038/s44161-025-00652-y

Low-dose interleukin-2 induces clonal expansion of BACH2-repressed effector regulatory T cells following acute coronary syndrome

2025

Journal Article

Temporal multi-omics analysis of COVID-19 in end-stage kidney disease

Stephenson, Emily, Macdonald-Dunlop, Erin, Dratva, Lisa M., Lindeboom, Rik G.H., Tuong, Zewen Kelvin, Tun, Win Min, Kretschmer, Lorenz, Buang, Norzawani B., Ballereau, Stephane, Cabantaus, Mia, Peñalver, Ana, Prigmore, Elena, Ferdinand, John R., Stewart, Benjamin J., Gisby, Jack, Malik, Talat H., Clarke, Candice L., Medjeral-Thomas, Nicholas, Prendecki, Maria, McAdoo, Stephen, Portet, Anais, Willicombe, Michelle, Sandhu, Eleanor, Pickering, Matthew C., Botto, Marina, Teichmann, Sarah A., Haniffa, Muzlifah, Clatworthy, Menna R., Thomas, David C. and Peters, James E. (2025). Temporal multi-omics analysis of COVID-19 in end-stage kidney disease. Cell Genomics, 5 (8) 100918, 100918. doi: 10.1016/j.xgen.2025.100918

Temporal multi-omics analysis of COVID-19 in end-stage kidney disease

2025

Journal Article

GFI1-driven transcriptional and epigenetic programs maintain CD8+ T cell stemness and persistence

Chaudhry, M. Zeeshan, Chen, Evelyn, Man, Hiu On, Jones, Aneesha, Denman, Renae, Yu, Huiyang, Huang, Qiutong, Ilich, Adrian, Schreuder, Jaring, Navarro, Severine, Tuong, Zewen K. and Belz, Gabrielle T. (2025). GFI1-driven transcriptional and epigenetic programs maintain CD8+ T cell stemness and persistence. Nature Immunology, 26 (6) 1418, 894-907. doi: 10.1038/s41590-025-02151-5

GFI1-driven transcriptional and epigenetic programs maintain CD8+ T cell stemness and persistence

2025

Journal Article

Data standards for single‐cell RNA‐sequencing of paediatric cancer

Xu, Xiaohan, Saxon, John, Soon, Megan Sioe Fei, Lee, Colin Y. C. and Tuong, Zewen Kelvin (2025). Data standards for single‐cell RNA‐sequencing of paediatric cancer. Clinical & Translational Immunology, 14 (5) e70033, e70033-5. doi: 10.1002/cti2.70033

Data standards for single‐cell RNA‐sequencing of paediatric cancer

2025

Journal Article

CellPhoneDB v5: inferring cell–cell communication from single-cell multiomics data

Troulé, Kevin, Petryszak, Robert, Cakir, Batuhan, Cranley, James, Harasty, Alicia, Prete, Martin, Tuong, Zewen Kelvin, Teichmann, Sarah A., Garcia-Alonso, Luz and Vento-Tormo, Roser (2025). CellPhoneDB v5: inferring cell–cell communication from single-cell multiomics data. Nature Protocols 6619, 1-29. doi: 10.1038/s41596-024-01137-1

CellPhoneDB v5: inferring cell–cell communication from single-cell multiomics data

2025

Journal Article

Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge

Coates, Matthew L., Richoz, Nathan, Tuong, Zewen K., Bowyer, Georgina S., Lee, Colin Y. C., Ferdinand, John R., Gillman, Eleanor, McClure, Mark, Dratva, Lisa, Teichmann, Sarah A., Jayne, David R., Di Marco Barros, Rafael, Stewart, Benjamin J. and Clatworthy, Menna R. (2025). Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge. Nature Immunology, 26 (2) 838328, 215-229. doi: 10.1038/s41590-024-02064-9

Temporal profiling of human lymphoid tissues reveals coordinated defense against viral challenge

2025

Journal Article

Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR

Lam, Pui Yeng, Omer, Natacha, Wong, Josh K. M., Tu, Cui, Alim, Louisa, Rossi, Gustavo R., Victorova, Maria, Tompkins, Hannah, Lin, Cheng-Yu, Mehdi, Ahmed M., Choo, Amos, Elliott, Melissa R., Coleborn, Elaina, Sun, Jane, Mercer, Timothy, Vittorio, Orazio, Dobson, Lachlan J., Mclellan, Alexander D., Brooks, Andrew, Tuong, Zewen Kelvin, Cheetham, Seth W., Nicholls, Wayne and Souza-Fonseca-Guimaraes, Fernando (2025). Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. Clinical and Translational Medicine, 15 (1) e70140, 1-21. doi: 10.1002/ctm2.70140

Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR

2025

Journal Article

dandelionR: single-cell immune repertoire trajectory analysis in R

Yu, Jiawei, Xu, Xiaohan, Borcherding, Nicholas and Tuong, Zewen Kelvin (2025). dandelionR: single-cell immune repertoire trajectory analysis in R. Computational and Structural Biotechnology Journal, 27, 2890-2897. doi: 10.1016/j.csbj.2025.06.047

dandelionR: single-cell immune repertoire trajectory analysis in R

2024

Journal Article

An organotypic atlas of human vascular cells

Barnett, Sam N., Cujba, Ana-Maria, Yang, Lu, Maceiras, Ana Raquel, Li, Shuang, Kedlian, Veronika, Pett, J. Patrick, Polanski, Krzysztof, Miranda, Antonio M. A., Xu, Chuan, Cranley, James, Kanemaru, Kazumasa, Lee, Michael, Mach, Lukas, Perera, Shani, Tudor, Catherine, Joseph, Philomeena D., Pritchard, Sophie, Toscano-Rivalta, Rebecca, Tuong, Kelvin, Bolt, Liam, Petryszak, Robert, Prete, Martin, Cakir, Batuhan, Huseynov, Alik, Sarropoulos, Ioannis, Chowdhury, Rasheda A., Elmentaite, Rasa, Madissoon, Elo ... Teichmann, Sarah A. (2024). An organotypic atlas of human vascular cells. Nature Medicine, 30 (12), 3468-3481. doi: 10.1038/s41591-024-03376-x

An organotypic atlas of human vascular cells

2024

Conference Publication

Early human lung immune cell development and its role in epithelial cell fate

Barnes, Josephine, Yoshida, Masahiro, He, Peng, Worlock, Kaylee, Lindeboom, Rik, Suo, Chenqu, Pett, J. Patrick, Wilbrey-Clark, Anna, Dann, Emma, Mamanova, Lira, Richardson, Laura, Polanski, Krzysztof, Pennycuick, Adam, Allen-Hytinnen, Jessica, Herczeg, Iván, Arzili, Romina, Hynds, Robert, Teixeira, Vitor, Haniffa, Muzlifah, Lim, Kyungtae, Sun, Dawei, Rawlins, Emma, Oliver, Amanda, Lyons, Paul, Marioni, John, Ruhrberg, Christiana, Tuong, Zewen, Clatworthy, Menna, Reading, James ... Nikolić, Marko (2024). Early human lung immune cell development and its role in epithelial cell fate. ERS Congress 2024, Vienna, Austria, 7-11 September 2024. Sheffield, United Kingdom: European Respiratory Society. doi: 10.1183/13993003.congress-2024.oa1893

Early human lung immune cell development and its role in epithelial cell fate

2024

Conference Publication

Self or Bacteria-reactive Th17 Expand from Conventional and Regulatory T Cells in Parabacteroides Goldsteinii Gnotobiotic Arthritic SKG Mice, in Context of Interferon-driven Synovial Inflammatory Macrophages and Reduced Bacterial Immune Regulation

Cai, Benjamin, Tuong, Zewen Kelvin, Morrison, Mark, Bergot, Anne-Sophie and Thomas, Ranjeny (2024). Self or Bacteria-reactive Th17 Expand from Conventional and Regulatory T Cells in Parabacteroides Goldsteinii Gnotobiotic Arthritic SKG Mice, in Context of Interferon-driven Synovial Inflammatory Macrophages and Reduced Bacterial Immune Regulation. ACR Convergence 2024, Washington, DC United States, 15–19 November 2024. Hoboken, NJ United States: John Wiley & Sons.

Self or Bacteria-reactive Th17 Expand from Conventional and Regulatory T Cells in Parabacteroides Goldsteinii Gnotobiotic Arthritic SKG Mice, in Context of Interferon-driven Synovial Inflammatory Macrophages and Reduced Bacterial Immune Regulation

2024

Journal Article

Computational estimation of clonal diversity in autoimmunity

Tuong, Zewen Kelvin, van der Merwe, Rohan, Canete, Pablo F and Roco, Jonathan A (2024). Computational estimation of clonal diversity in autoimmunity. Immunology and Cell Biology, 102 (8), 692-701. doi: 10.1111/imcb.12801

Computational estimation of clonal diversity in autoimmunity

2024

Journal Article

Embracing computational immunology

Cañete, Pablo F and Tuong, Zewen Kelvin (2024). Embracing computational immunology. Immunology & Cell Biology, 102 (8), 663-664. doi: 10.1111/imcb.12817

Embracing computational immunology

2024

Conference Publication

The effect of low-dose interleukin-2 on the T cell receptor landscape in patients with acute myocardial infarction

Case, Ayden, O'Brien, James, Sriranjan, Rochelle, Tuong, Zewen Kelvin, Cheriyan, Joseph, Clatworthy, Menna, Mallat, Ziad and Zhao, Tian (2024). The effect of low-dose interleukin-2 on the T cell receptor landscape in patients with acute myocardial infarction. EAS Congress 2024, Lyon, France, 26-29 May 2024. Elsevier. doi: 10.1016/j.atherosclerosis.2024.118476

The effect of low-dose interleukin-2 on the T cell receptor landscape in patients with acute myocardial infarction

2024

Conference Publication

LOW DOSE INTERLEUKIN 2 EXPANDS PLASMABLASTS WITH A REGULATORY B CELL PHENOTYPE POST-MT

O'Brien, James, Case, Ayden, Sriranjan, Rochelle, Tuong, Zewen Kelvin, Cheriyan, Joseph, Clatworthy, Menna, Mallat, Ziad and Zhao, Tian (2024). LOW DOSE INTERLEUKIN 2 EXPANDS PLASMABLASTS WITH A REGULATORY B CELL PHENOTYPE POST-MT. 92nd Congress of the European-Atherosclerosis-Society (EAS), Lyon France, May 26-29, 2024. CLARE: ELSEVIER IRELAND LTD.

LOW DOSE INTERLEUKIN 2 EXPANDS PLASMABLASTS WITH A REGULATORY B CELL PHENOTYPE POST-MT

2024

Conference Publication

Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI

O'Brien, James, Case, Ayden, Sriranjan, Rochelle, Tuong, Zewen Kelvin, Cheriyan, Joseph, Clatworthy, Menna, Mallat, Ziad and Zhao, Tian (2024). Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI. EAS Congress 2024, Lyon, France, 26-29 May 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.atherosclerosis.2024.118287

Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI

2024

Journal Article

Measuring single-cell immune clonality to track haematological cancers

Choo, Amos and Tuong, Zewen Kelvin (2024). Measuring single-cell immune clonality to track haematological cancers. Clinical and Translational Medicine, 14 (8) e1780, e1780. doi: 10.1002/ctm2.1780

Measuring single-cell immune clonality to track haematological cancers

2024

Conference Publication

THE EFFECT OF LOW-DOSE INTERLEUKIN-2 ON THE T CELL RECEPTOR LANDSCAPE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Case, Ayden, O'Brien, James, Sriranjan, Rochelle, Tuong, Zewen Kelvin, Cheriyan, Joseph, Clatworthy, Menna, Mallat, Ziad and Zhao, Tian (2024). THE EFFECT OF LOW-DOSE INTERLEUKIN-2 ON THE T CELL RECEPTOR LANDSCAPE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 92nd Congress of the European-Atherosclerosis-Society (EAS), Lyon France, May 26-29, 2024. CLARE: ELSEVIER IRELAND LTD.

THE EFFECT OF LOW-DOSE INTERLEUKIN-2 ON THE T CELL RECEPTOR LANDSCAPE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION

Funding

Current funding

  • 2026 - 2030
    Thwarting Rare Blood Cancer in Kids with Single-cell Innovation (TRaCKIn)
    NHMRC Investigator Grants
    Open grant
  • 2024 - 2029
    Paediatric Immune Cell Atlas for Immunotherapy Innovation (PICACHIU)
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2024 - 2026
    A novel approach to engineer personalized vaccines to prevent cutaneous Squamous Cell Carcinoma.
    TRI Leading Innovations through New Collaborations Scheme
    Open grant
  • 2024 - 2026
    Deciphering interleukin-21 agonism in boosting CD8+ T cell mediated anti-tumour immunity to engineer next-generation immunotherapies
    Cure Cancer Early Career Research Grants
    Open grant

Past funding

  • 2017 - 2018
    Is there really a viral cause for skin cancer?
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2017 - 2019
    Approaching antigen-presenting cell immunotherapy for cervical cancers using single-cell transcriptomics
    Advance Queensland Research Fellowships
    Open grant

Supervision

Availability

Dr Kelvin Tuong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Harnessing adaptive immune receptors to monitor paediatric immunity in cancer and enhance neoantigen vaccine pipeline

    Principal Advisor

    Other advisors: Professor Di Yu, Dr Jazmina Gonzalez Cruz

  • Doctor Philosophy

    A Comprehensive Paediatric Immune Cell Atlas for Children's Immunotherapy Innovation

    Principal Advisor

    Other advisors: Dr Quan Nguyen, Professor Di Yu

  • Doctor Philosophy

    Advancing Paediatric Cancer Immunotherapy with Antigen Receptors and Artificial Intelligence

    Principal Advisor

    Other advisors: Dr Yang Yang

  • Doctor Philosophy

    Development of novel vaccines for cancer immunotherapy

    Associate Advisor

    Other advisors: Professor Maher Gandhi, Honorary Professor Kristen Radford

  • Doctor Philosophy

    Pipelines to model immune signalling networks in barrier tissue protection

    Associate Advisor

    Other advisors: Professor Gabrielle Belz

  • Doctor Philosophy

    Decipher interleukin-21 signaling and engineer next generation immunotherapies

    Associate Advisor

    Other advisors: Dr Zhian Chen

  • Doctor Philosophy

    Investigate T cell specificity and function in immune responses by systems immunology

    Associate Advisor

    Other advisors: Dr Yang Yang, Professor Di Yu

Completed supervision

Media

Enquiries

Contact Dr Kelvin Tuong directly for media enquiries about:

  • Cancer
  • Genomics
  • Immunology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au